Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Midol is a brand of over-the-counter (OTC) combination medications primarily marketed for the relief of symptoms associated with premenstrual syndrome (PMS) and menstruation, such as cramps, bloating, fatigue, headache, and backache. The specific active ingredients in Midol formulations have varied over time and across different sub-brands. Common formulations include combinations of analgesics (like acetaminophen, aspirin, ibuprofen, or naproxen sodium), diuretics (like pamabrom or caffeine), antihistamines (like pyrilamine maleate or diphenhydramine citrate), and stimulants (like caffeine or cinnamedryl). For example, Midol Complete typically contains acetaminophen, caffeine, and pyrilamine maleate. Midol Teen has contained acetaminophen and pamabrom, while older formulations included ingredients like cinnamedryl and aspirin. The drug works by targeting various symptoms through the combined actions of its active ingredients.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Midol.